LYSSN.IO, INC
Seattle, US
Lyssn offers an AI and natural language processing platform that transcribes and evaluates therapy sessions to measure and improve fidelity to evidence-based practices, and to deliver clinical training. It serves health and human services, behavioral health, and crisis care organizations.
Founders & leadership
SF
Seth FeuersteinNamed on SEC filing
ZE
Zachary E. ImelNamed on SEC filing
DC
David C. AtkinsNamed on SEC filing
MJ
Michael J. TananaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements▶$3.2MraisedApr 2026 · 7 investors · Other TechnologyRule 506(b)
▶$3.2MraisedApr 2026 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Seth FeuersteinDirector
- Zachary E. ImelDirector, Promoter
- David C. AtkinsExecutive Officer, Director, Promoter
- Michael J. TananaDirector, Promoter
- Offering amount
- $3.2M
- Amount sold
- $3.2M
- First sale
- Apr 2025
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$1.1MraisedNov 2022 · 18 investors · Other TechnologyRule 506(b)
▶$1.1MraisedNov 2022 · 18 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Seth FeuersteinDirector
- Zachary E. ImelDirector
- David C. AtkinsExecutive Officer, Director, Promoter
- Michael J. TananaDirector
- Offering amount
- $1.2M
- Amount sold
- $1.1M
- First sale
- Mar 2022
- Incorporated
- Corporation, Washington, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 9 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $275.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2022 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2022 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2021 | $459.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2020 | $971.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $397.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $146.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does LYSSN.IO, INC do?
- Lyssn offers an AI and natural language processing platform that transcribes and evaluates therapy sessions to measure and improve fidelity to evidence-based practices, and to deliver clinical training. It serves health and human services, behavioral health, and crisis care organizations.
- Where is LYSSN.IO, INC headquartered?
- LYSSN.IO, INC is headquartered in Seattle, US.